• Overview
  • News
  • Events & Presentations
    • Events & Presentations
    • Investor Days
    • Scientific Medical Meetings
    • Development Programs
  • Stock Info
    • Stock Info
    • Stock Quote
    • Stock Chart
    • Investment Calculator
    • Analyst Coverage
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Governance
    • Governance Documents
    • Leadership Team
    • Committee Composition
  • Resources
    • Investor FAQs
    • Information Request Form
    • Investor Email Alerts
    • Investor Contacts
  • Statements & Perspectives
NASDAQ: MRNA   $0.00 VOL:   $0.00
Moderna logo
NASD: MRNA   $0.00   Vol:   $0.00
Moderna logo
  • About Us
  • The Power Of MRNA
  • Research
  • Responsibility
  • Overview
  • News
  • Events & Presentations
    • Events & Presentations
    • Investor Days
    • Scientific Medical Meetings
    • Development Programs
  • Stock Info
    • Stock Info
    • Stock Quote
    • Stock Chart
    • Investment Calculator
    • Analyst Coverage
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Governance
    • Governance Documents
    • Leadership Team
    • Committee Composition
  • Resources
    • Investor FAQs
    • Information Request Form
    • Investor Email Alerts
    • Investor Contacts
  • Statements & Perspectives

Joint Statement from Moderna and Takeda on the Investigation of Suspended Lots of Moderna’s COVID-19 Vaccine in Japan

September 1, 2021

Download PDF >

Quick Links

SEC Filings

Investor FAQs

Information Request Form

IR Contact

Ir@modernatx.com

Investor Email Alerts

Unsubscribe

Investors

Investor overview

Newsroom

Press releases

Media kit

Media Center

All Media

Blogs

Partnerships

Strategic collaborators

Careers

Company culture

People behind the science

Join our team

Innovation Incubator

New venture labs

  • Terms of Use
  • Site Map
  • Privacy Policy
  • Contact Moderna

© 2025 Moderna, Inc.

Share by: